Out For Tender › Estados Unidos › Equipamiento y artículos médicos, farmacéuticos y de higiene personal

NOI - DNA Sequencing of Bone Marrow Failure Syndro

This tender has closed. It stays online as a record of what was advertised.

Órgano de contratación: NATIONAL INSTITUTES OF HEALTH OLAO, Health and Human Services, Department of
País: Estados Unidos
Categoría: Equipamiento y artículos médicos, farmacéuticos y de higiene personal
Fecha límite: Cerrada (2 Nov 2026 09:00 UTC-5)
Publicada: 22 Oct 2026
Procedimiento: Combined Synopsis/Solicitation

Leer el anuncio oficial y licitar → La presentación de ofertas se realiza siempre en el portal del órgano de contratación, nunca aquí.

Qué solicita el órgano de contratación

(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested, and a separate written solicitation will not be issued. (ii) The solicitation number is 75N98027Q00027. This solicitation is issued as a Notice of Intent (NOI) for a non-competitive combined synopsis/solicitation to award a contract or purchase order without providing for full and open competition (including brand-name, if applicable). This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold. Additional authority includes 41 U.S.C. 1901 and FAR 6.302-3(a)(2)(ii). The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, intends to negotiate and award a firm-fixed-price purchase order on a non-competitive basis to Integrated DNA Technologies, Inc. (IDT), 1710 Commercial Park, Coralville, IA 52241, for custom-designed ArcherDX VariantPlex Next-Generation Sequencing (NGS) target-enrichment library preparation kits. Integrated DNA Technologies, Inc. is the sole owner, manufacturer, and distributor of the proprietary ArcherDX VariantPlex Anchored Multiplex PCR (AMP) chemistry, which has been utilized by the NHLBI Hematology Branch since 2019 to perform error-correcting sequencing (ECS) and is required to maintain scientific continuity, prevent technical batch effects across longitudinal patient cohorts, and ensure compatibility with the laboratory¿s established Archer Analysis bioinformatics pipeline. All responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the agency. (iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2026-01, effective 03/13/2026. (iv) The associated NAICS code is 325413 (In-Vitro Diagnostic Substance Manufacturing) and the small business size standard is 1,250 employees. This requirement is not set aside for small business.

Idioma de este anuncio: English. El título y la descripción se muestran tal como los publicó el órgano de contratación.

How this compares

This is one of 76 open tenders in Estados Unidos for Equipamiento y artículos médicos, farmacéuticos y de higiene personal.
Bidders were given 11 days from publication to the deadline; the median for open tenders in Estados Unidos is 25 days.